GNPDA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.097000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.828800E-01
Normal-vs-Stage2
6.833800E-01
Normal-vs-Stage3
1.931640E-01
Normal-vs-Stage4
9.689200E-01
Stage1-vs-Stage2
5.938600E-01
Stage1-vs-Stage3
1.646760E-01
Stage1-vs-Stage4
9.945400E-01
Stage2-vs-Stage3
1.257360E-01
Stage2-vs-Stage4
6.643400E-01
Stage3-vs-Stage4
1.317150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.440200E-01
Normal-vs-AfricanAmerican
4.499400E-01
Normal-vs-Asian
3.169200E-01
Caucasian-vs-AfricanAmerican
5.736200E-01
Caucasian-vs-Asian
3.225600E-01
AfricanAmerican-vs-Asian
8.550800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.788600E-01
Normal-vs-Female
6.283200E-01
Male-vs-Female
5.514000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.004200E-01
Normal-vs-Age(41-60Yrs)
9.823200E-01
Normal-vs-Age(61-80Yrs)
5.595400E-01
Normal-vs-Age(81-100Yrs)
8.723800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.527400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.546800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.809400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.361600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.510600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.708590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.028600E-01
Normal-vs-Daily Drinker
5.055000E-01
Normal-vs-Weekly Drinker
8.340400E-01
Normal-vs-Occasional Drinker
7.888400E-01
Normal-vs-Social Drinker
8.546000E-01
Non Drinker-vs-Daily Drinker
3.510600E-01
Non Drinker-vs-Weekly Drinker
1.605170E-01
Non Drinker-vs-Occasional Drinker
9.753700E-02
Non Drinker-vs-Social Drinker
3.732300E-02
Daily Drinker-vs-Weekly Drinker
5.072200E-01
Daily Drinker-vs-Occasional Drinker
4.248800E-01
Daily Drinker-vs-Social Drinker
1.699160E-01
Weekly Drinker-vs-Occasional Drinker
9.982200E-01
Weekly Drinker-vs-Social Drinker
5.267800E-01
Occasional Drinker-vs-Social Drinker
4.537600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.998000E-01
Normal-vs-Grade 2
8.217400E-01
Normal-vs-Grade 3
7.519400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.197200E-01
Grade 1-vs-Grade 3
8.508000E-02
Grade 1-vs-Grade 4
7.998000E-01
Grade 2-vs-Grade 3
9.653600E-02
Grade 2-vs-Grade 4
8.217400E-01
Grade 3-vs-Grade 4
7.519400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.262200E-01
Normal-vs-NonDiabetic
7.669200E-01
Diabetic-vs-NonDiabetic
2.936800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.331000E-01
Normal-vs-NoPancreatitis
6.938800E-01
Pancreatitis-vs-NoPancreatitis
3.413400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.911000E-01
Normal-vs-N1
6.524600E-01
N0-vs-N1
7.871000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.468000E-01
Normal-vs-TP53-NonMutant
7.511800E-01
TP53-Mutant-vs-TP53-NonMutant
1.673600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
